in Featured, Funding, Medical Countermeasures NIAID Backs VesiculoVax Vaccine for Ebola, Marburg, and Lassa Viruses
in Emerging Threats, Featured, Funding, Medical Countermeasures, Policy & Initiatives, Public Health New Coalition for Epidemic Preparedness Sets Sights on MERS-CoV, Lassa and Nipah
in Biodetection, Industry News Zalgen and NOWDx Collaborate on Rapid Diagnostics for Ebola, Tropical Diseases
in Biosecurity, Featured, Funding, Medical Countermeasures Advanced Development of Filovirus and Lassa Fever Vaccines
in Biosecurity, Emerging Threats, Featured, Medical Countermeasures, Pathogens Handicapping Ebola to Buy Immune System Time to Respond
